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ABSTRACT: IMMU -21 a polyherbal immunomodulator effectively enhanced the immune status 
of animals treated with cytotoxic and immunosuppressive agents like cyclophosphamide and 
azathioprine. Leucopenia, lymphopenia and neutropenia in rats induced by cyclophosphamide 
were significantly minimized in IMMU-21 pre treated animals.  IMMU-21 strengthened the host 
immune status against bacterial endotoxin. Cell mediated immune response was also found to be 
maintained at the normal level in immunocompromised mice treated with IMMU 21.  The results 
of the experiments are of immense clinical significance IMMU -21 shows promise as a useful 
immunoadjuvant which may have various therapeutic applications. 
 
INTRODUCTION  
 
Immunomodulators of herbal origin have 
attracted geat attention of scientific 
community during recent years.  Medicinal 
plants, commonly used in herbal remedies, 
are known to have immunomodulatory 
properties. The use of herbal 
immunomodulators to restore and rejuvenate 
positive health and to maintain organic 
balance, has been in vogue since ancient 
time (1). 
 
IMMU-21 a polyherbal formulation, (Envin 
Bioceuticals, A division of Indian herbs, 
saharanpur). Contains the extracts of 
different immuno- active plants viz Ocimum 
Sanctum, Withania somnifera,  Tinospora 
cordifolia and Emblica officinale as major 
constituents in their optimum 
concentrations. Immunoregulatory profile of 
these plants are well document (2-11). 
 
IMMU- 21 was reported to have 
immunostimulatory effects on 
immunocompetant hosts (12,13). Both 
humoral and cellular immune response were 
found to be stimulated in experimental 
animals treated with IMMU-21 (12).   
IMMU – 21 was reported to be effective in 
stimulating the phagocytic activity of 
macrophage and blastogenic response of 
murine spleenic lymphocytes to antigenic 
challenge (13).  Present study was designed 
to explore the effects of IMMU-21 in 
immunocompromised animals. 
 
MATERIALS AND METHODS  
 
Wistar albino rats (approx. 125gm) and 
Swiss albino mice (approx 30 gm) were 
used in the present experiments. The 
animals were acclimatized to laboratory 
conditions prior to experimentation. The 
animals were grouped into plastic cages in 
an airconditioned room (23 ± 1
oC) with 12 
hours light and dark cycle.  These were 
maintained with pellet diet and clean tap 
water and libitum.  IMMU-21 was dissolved 
in distilled water freshly before use and 
administered to experimental animals (30 
mg/kg; p.o) at the rate of 0.5ml/100 gm in 
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rats and 1 ml/100 gm in mice once daily at 
10-00hr A.M). 
 
Assessment of host resistance against 
myelosuppression: 
 
Rats were used in this experiment.  The 
animals were divided into three groups of 
eight animals each.  The rats of group I 
served as healthy control.  The rats of group 
II and III were treated with 
cyclophosphamide (30 mg/kg; i.p for 3 
days).  The rats of group III were treated 
with IMMU-21 from day (-7) to day (+7) of 
the experiment. Blood samples were 
collected from the retro-orbital venous 
plexus of each rat after 24 hour of last 
product administration.  Total and 
differential leucocyte count were performed 
using standard procedure. 
 
Assessment of host resistance against 
bacterial endotoxin 
 
Mice were used in this experiment.  The 
animals were divided into two groups of ten 
animals each.  The animals were treated 
with cyclophosphamide (75 mg/kg; i.p) on 
day 0 of the experiment. The mice of group I 
served as control and that of group II were 
treated with IMMU-21 from day (10) to day 
(+4).  All the animals were challenged with 
E.Coli lipopolysaccharide (0.127:B8), 
(Sigma) on day (=4) through intraperitoneal 
injection (400µg/mouse).  Mortality was 
recorded upto 48 hours post E.Coli LPS 
challenge (14). 
 
Assessment of cell medicated immunity 
 
Mice were used in this experiment.  The 
animals were divided into three groups on 
eight animals each.  All the animals were 
sensitized with 3 mg of ovalbumin dissolved 
in 0.1 ml of normal saline emulsified with 
equal volume if freund’s complete adjuvant. 
They were injected (S.C) in the back.  The 
mice of group II and III were treated with 
azathioprine (3 mg/kg);i.p) from the day of 
sanitization for 10 days (15).  The animals 
of group III were treated with IMMU-21(30 
mg/kg, orally) from the day of sensitizatioin 
for 21 days. On 22
nd day, all the animals 
were challenged with 50µg of ovalbumin (S, 
C) in 0.05 ml phosphate buffer (pH 7.4) in 
left hind foot pad.  The increase in foot pad 
thickness was measured 24 hours after 
challenge with the help of a digital caliper.  
The degree of hypersensitivity reaction was 
expressed as the percent increase in foot pad 
thickness over the non sensitized foot (16). 
 
RESULTS AND DISCUSSION  
 
The experiments performed in this study 
indicate that IMMU-21 possesses 
immunostimulant properties.  Total 
leucocyte, absolute neutrophil and absolute 
lymphocyte counts of cyclophosphamide 
treated rats were significantly reduced as 
compared to that of the control 
animls.IMMU-21 prevented the 
myelosupressive effects of cyclophospamide 
to a significant extent (Table -1).   
Overwhelming sepsis is one of the major 
cause of death in patients with malignancy 
(17), that occurs due to immunosuppression 
induced by the disease and cytotoxic 
chemotherapy. IMMU-21 effectively 
reduced the cyclophosphamide induced 
myelosuppression.  Similar 
immunostimulatory action was also noted in 
Tinospora cordifolia against 
cyclophosphamide – induced 
myelosuppression.  Same action was also 
reflected in IMMU-21. 
 
Fig 1 shows that pretreatment of 
immunocompromised mice with IMMU-21 
reduced their susceptibility to E.coli 
endotoxin. Earlier it was found that 
pretreatment of mice with IMMU-21 as well 
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as with its active ingredients (e.g. W 
Somnifera and T. cordifolia) significantly 
reduced the mortality from E. Coli 
endotoxin and E.coli induced peritonitis, 
respectively (12,18).  The results indicate 
that IMMU 21 strenthens both 
immunocompetant and 
immunocompromised host defence 
mechanisms. 
 
Fig 2. shows that cell-mediated immune 
response as assayed by delayed type 
hypersensitivity reaction was significantly 
depressed in azathioprine treated mice. 
Simultaneous treatment with IMMU-21 
effectively improved the cell-mediated 
immune function (15).  During cell-
mediated immune responses, sensitized T-
cells, when challenged by the antigen are 
converted to lymphoblasts and secrete 
lymphokines, attracting more scavenger 
cells to the site of reaction(16). Ovalbumin 
is a T-cell dependent antigen. So, 
augmentation of cell-mediated immune 
response to ovalbumin is suggestive of 
lymphokine mediated reaction (19).  IMMU-
21 was found to optimise the cell-mediated 
immune function in immunocompromised 
hosts. Earlier it was reported that IMMU-21 
enhanced the cell-mediated immune 
response in immunocompetant hosts (12).   
Moreover, it was also reported that IMMU-
21 enhanced the cell- mediated immune 
response in immunocompetant hosts (12).   
Was capable of enchancing blastogenic 
response of murine spleenic lymphocytes to 
non-specific antigenic challenge(13).  The 
present findings leads to assume that 
augmentation of cell-mediated immune 
status of IMMU-21 treated animals may 
follow through favorable secretion of 
lymphokines. 
 
The present study clearly demonstrates the 
immunostimulatory actions of IMMU-21 in 
immunocompromised animals.  In view of 
its efficacy, IMMU-21 shows promise as a 
useful immunomodulator which may have 
various therapeutic applications, like therapy 
of infections prophylaxis of opportunistic 
infections of patients at risk as an adjuvant 
in combination with vaccines and in the 
therapy of malignant diseases. 
 
TABLE -1 : EFFECT OF IMMU-21 ON LEUCOGRAM OF MYELOSUPPRESSED 
RATS. 
 
Group Treatment    Total  WBC 
(X10
3/µl) 
Absolute 
Lymphocyte  
(X10
3/µl) 
Absolute 
neutrophil 
(X10
3/µl) 
I 
 
II 
 
III 
Vehicle control 
 
Cyclophosphamide 
 
Cyclophosphamide 
+ IMMU-21 
9.0 ± 0.81 
 
5.6 ± 0.62* 
 
 
7.9 ± 0.78 
7.28 ± 0.79 
 
4.11 ± 0.59* 
 
 
5.92 ± 0.73 
1.12 ± 0.13 
 
0.84 ± 0.07* 
 
 
1.08 ± 0.09 
   
 * Significant difference (P<0.05) as compared to control. 
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